Katja Becker

Thioredoxin reductase as a pathophysiological factor and drug target.

R. Schirmer, K. Becker, S. Müller, 2000, European journal of biochemistry.

A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.

R. Schirmer, K. Becker, C. Biot, 2001, Journal of medicinal chemistry.

The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli.

R. Schirmer, K. Becker, S. Gromer, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Redox processes in malaria and other parasitic diseases

R. Schirmer, K. Becker, A. Traxler, 1994, Histochemistry.